Press

The OakLabs GmbH receives High-Tech Gründerfonds seed funding for intelligent breeding methods

February 8, 2012

The development of new types of plants can be reduced by up to ten years with the reliable diagnostic DNA markers from OakLabs. With its seed investment, High-Tech Gründerfonds enables this young company to further develop its technology and to introduce it into the market.

The primary objective of plant breeding is to optimise specific traits such as resistances, crop yield or taste. „This is not always an easy task – particularly for traits, which are controlled by more than one gene“, Dr. Martina Schad, biochemist and one of the two founders of the OakLabs GmbH explains. Traits, which are only determined by one gene, can usually be reliably predicted with today’s DNA markers. In the case of complex traits such as crop yield or taste however, the prognosis does not provide sufficient reliability to be economically useful in breeding. „We are bridging this gap. OakLabs develops reliable diagnostic DNA markers for complex traits“, Dr. Schad states. The analysis of these markers allows for the prognosis of the traits at an early stage of development. „With the help of our technology, the offspring can be purposefully selected in regard to complex traits at a much earlier stage. In doing so, the developmental period for a new type of plant with improved quality characteristics is reduced by up to ten years.“

The founders combine in-depth knowledge in molecular biology with modern mathematics for their intelligent method. „We combine an innovative lab procedure, which is based on DNA microarrays, with dedicated algorithms“, Dr. Jim Kallarackal, theoretical quantum physicist and co-founder, explains. „We are using the investment High-Tech Gründerfonds made to develop our technology to market maturity and will launch it on the market in the summer of 2012.“

Kay Balster, investment manager at High-Tech Gründerfonds, explains the reasons for High-Tech Gründerfonds’ investment: „Although there are several competitors in the market, the technology developed by OakLabs convinced us. So far, it is not possible for the competitors to analyse a large number of DNA markers in a small amount of samples cost-effectively using the existing methods. However, the large number of DNA markers is imperative for developing reliable diagnostic DNA markers.“

In the future, more and more will be expected of domesticated plants. The agricultural area utilised for farming, which continues to decrease in size, as well as the increasing demand for foodstuffs calls for highly productive plants. „Plant breeding is a research-driven field with a large potential for growth. The market volume for OakLabs’ offer convinced us“, Balster states in conclusion for the decision to invest.

The OakLabs GmbH will make its technology available to animal and plant breeding clients as well as to research institutes in the autumn of 2012.

About the OakLabs GmbH
The OakLabs GmbH was founded in 2011 by Dr. Martina Schad and Dr. Jim Kallarackal. The OakLabs GmbH develops reliable diagnostic DNA markers for complex traits in plants. Their analysis allows for the prognosis of certain traits in the early developmental period of the plants and therefore, reduces the breeding of a new type of plant by up to ten years.

Contact:
OakLabs GmbH
Dr. Martina Schad
Neuendorfstraße 20b
16761 Hennigsdorf
Tel.: +49 178 357 67 21
m.schad@oak-labs.com
www.oak-labs.com

About High-Tech Gruenderfonds
High-Tech Gründerfonds invests risk capital in young, promising technology companies that implement auspicious research results in an entrepreneurial way. The start-up companies use the seed funding to help them conduct their research and development plans until a prototype/proof of concept is provided or the product is launched on the market. The fund generally invests EUR 500,000 million, and up to EUR 2 million is available per company. Investors in the public-private partnership include the Federal Ministry of Economics and Technology, the KfW Banking Group and the 12 industrial groups ALTANA, BASF, B. Braun, Robert Bosch, CEWE Color, Daimler, Deutsche Post DHL, Deutsche Telekom, Qiagen, RWE Innogy, Tengelmann and Carl Zeiss. High-Tech Gründerfonds has a total fund volume of approximately EUR 560.5 million (EUR 272 million for Fund I and EUR 288.5 million for fund II).

Contact:
High-Tech Gründerfonds Management GmbH
Kay Balster
Investmentmanager
Ludwig-Erhard-Allee 2
53175 Bonn
Tel: +49 228 823001-0
Fax: +49 228 823000-50
info@high-tech-gruenderfonds.de
www.high-tech-gruenderfonds.de

Stay up to date

Subscribe now and receive the latest press releases on investments and other news from High-Tech Gründerfonds. We inform you about important developments at HTGF and provide you with interesting news from our portfolio. Whether it’s a successful exit, a new exciting investment or HR news – you’ll be the first to know!

More Press posts

Press
19. April 2024

Successful Exit for HTGF: DocuWare Announces Acquisition of natif.ai 

With AI at the forefront of DocuWare’s product strategy, natif.ai’s technology further increases the competitive edge of the DocuWare platform. High-Tech Gründerfonds (HTGF) led the pre-seed round in 2020 as the first institutional investor of natif.ai and has actively supported the start-up on its path to becoming a leading provider in the field of intelligent document processing. Christian Arndt, Senior Investment Manager at HTGF: “The team of natif.ai has shown a great perfo
 
Press
11. April 2024

Scavenger AI secures €1.1m pre-seed funding for data-driven decision making 

The AI start-up helps companies to use their data to make the best possible decision under any circumstances.  Scavenger AI receives € 1.1 million from High-Tech Gründerfonds (HTGF), Calm/Storm Ventures, Femventix and the B4i Investment Fund.  The new capital will be used to launch the first version of the software on the market and serve customers on the waiting list.   Frankfurt, 8 April 2024 – The German data analytics & AI start-up
 
Press
10. April 2024

Proxima Fusion Raises €20M Seed to Accelerate Timeline to Fusion Power

Less than one year from its €7.5M pre-seed round, the first Max Planck fusion spin-out has delivered on its vision of simulation-enabled stellarator design. New funding supports expansion of the world-class team in Munich and its public-private partnerships in Europe to build on existing momentum. Proxima Fusion directly builds on €1.3B of public investment in the ground-breaking W7-X experiment in Germany. Munich, Germany, April 10, 2024 – Proxima Fusion, the first spi